Rallybio Corp short interest in 2023
In 2023, Rallybio Corp's disclosed short interest ran from 2.23% of shares outstanding on 13 Jan 2023 to 4.80% on 15 Dec 2023, a change of +2.57 percentage points. The year's high was 5.65% on 15 Nov 2023 and its low 2.00% on 15 Jun 2023, averaging 3.03% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 53.93 days on 31 Oct 2023. Full history: Rallybio Corp.
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 2.23% (13 Jan 2023)
- End of year
- 4.80% (15 Dec 2023)
- Change
- +2.57 pp
- High
- 5.65% (15 Nov 2023)
- Low
- 2.00% (15 Jun 2023)
- Average
- 3.03%
- Highest days to cover
- 53.93 (31 Oct 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 2.23% | 18.74 | |
| 31 Jan 2023 | 2.28% | 10.29 | |
| 15 Feb 2023 | 2.47% | 18.97 | |
| 28 Feb 2023 | 2.48% | 16.04 | |
| 15 Mar 2023 | 2.33% | 7.64 | 10-K filed, results (8-K) |
| 31 Mar 2023 | 2.40% | 15.41 | |
| 14 Apr 2023 | 2.43% | 16.27 | |
| 28 Apr 2023 | 2.46% | 39.27 | |
| 15 May 2023 | 2.46% | 36.64 | 10-Q filed, results (8-K) |
| 31 May 2023 | 2.46% | 17.29 | |
| 15 Jun 2023 | 2.00% | 7.51 | |
| 30 Jun 2023 | 2.84% | 3.38 | |
| 14 Jul 2023 | 2.98% | 21.91 | |
| 31 Jul 2023 | 2.81% | 20.27 | |
| 15 Aug 2023 | 2.79% | 31.14 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 2.66% | 38.09 | |
| 15 Sep 2023 | 2.65% | 27.64 | |
| 29 Sep 2023 | 2.68% | 22.96 | |
| 13 Oct 2023 | 2.56% | 18.03 | |
| 31 Oct 2023 | 5.61% | 53.93 | |
| 15 Nov 2023 | 5.65% | 19.62 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 5.61% | 15.33 | |
| 15 Dec 2023 | 4.80% | 11.04 |
See also: Rallybio Corp's full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.